Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record's revision history now shows a new revision label v3.5.4, replacing the previous v3.5.3, indicating an updated version of the page.
    Difference
    0.1%
    Check dated 2026-05-15T14:31:17.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page footer site revision/version was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The revision label was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:08:54.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and v3.4.3 removed, reflecting an update to the study protocol version.
    Difference
    0.1%
    Check dated 2026-03-18T21:55:47.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a maintenance/versioning update that does not modify the study details or other substantive content on the page.
    Difference
    0.1%
    Check dated 2026-03-11T19:57:51.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the funding-lapse notice (v3.4.1) was removed. There are no changes to the core study details, eligibility criteria, or outcomes.
    Difference
    0.5%
    Check dated 2026-02-11T02:12:50.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.